Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Other Working Capital Changes (2018 - 2019)

Vertex Pharmaceuticals (VRTX) posted Other Working Capital Changes of $51.4 million for Q2 2026, up 129.64% on a QoQ basis from -$173.4 million in Q1 2026, and down 32.72% year-over-year from $76.4 million in Q2 2025.

Analysis

Vertex Pharmaceuticals (VRTX) Other Working Capital Changes (2018 - 2019) Analysis & Trends

Vertex Pharmaceuticals has reported Other Working Capital Changes for 18 years, with the latest figure at $51.4 million in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes fell 32.72% year-over-year to $51.4 million in Q2 2026; TTM through Jun 2026 was $169.5 million, a 31.68% decrease from a year earlier, with the FY2025 full-year figure at $396.0 million, up 97.7% from the prior year.
  • Other Working Capital Changes was $35.7 million for Q1 2019 at Vertex Pharmaceuticals, down from $38.8 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $451.3 million in Q4 2023, with the low at -$173.4 million in Q1 2026.
  • Average Other Working Capital Changes over 5 years is $74.8 million, with a median of $46.2 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes surged 1889.31% in 2022, then tumbled 717.08% in 2026.
  • Over 5 years, Other Working Capital Changes stood at $284.5 million in 2022, then surged by 58.63% to $451.3 million in 2023, then sank by 63.53% to $164.6 million in 2024, then jumped by 52.25% to $250.6 million in 2025, then sank by 79.49% to $51.4 million in 2026.
  • The last three Other Working Capital Changes figures came in at $51.4 million (Q2 2026), -$173.4 million (Q1 2026), and $250.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 35.68 Mn
Mar 31, 2019 35.68 Mn
Mar 31, 2018 38.82 Mn
Mar 31, 2018 38.82 Mn
API Access

Vertex Pharmaceuticals Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=VRTX&period=max&api_key=YOUR_API_KEY